Literature DB >> 55322

The association of alpha2-macroglobulin with lymphocyte membranes in chronic lymphocytic leukaemia and other disorders.

K James, A M Tunstall, A C Parker, J N McCormick.   

Abstract

The association of alpha2-macroglobulin (alpha2M) with the surface membranes of human peripheral blood lymphocyte preparations has been investigated by the direct immunofluorescent technique. The percentage (and total number) of lymphocytes with detectable alpha2M on their surface is significantly increased in chronic lymphocytic leukaemia. The incidence of alpha2M-positive cells in normal and pathological conditions closely parallels that observed with conjugated antiserum to the kamma and gamma light chains of human immunoglobulin. It bears no relationship however to the plasma alpha2M levels or to the age of the donor. Additional blocking studies with aggregated human IgG, soluble antigen-antibody complexes and the F(ab')2 moiety of the anti-alpha2M, and indirect immunofluorescent studies with the latter, indicate that the fluorescence observed is not due to interaction of the conjugated reagent with Fc or C3 receptors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 55322      PMCID: PMC1538090     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY.

Authors:  H F CLARK; C C SHEPARD
Journal:  Virology       Date:  1963-08       Impact factor: 3.616

2.  Immunoglobulins on the surface of human lymphocytes.

Authors:  M Papamichail; J C Brown; E J Holborow
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

3.  Immunoglobulins on the surface of lymphocytes. 3. Bursal origin of surface immunoglobulins on chicken lymphocytes.

Authors:  E Rabellino; H M Grey
Journal:  J Immunol       Date:  1971-05       Impact factor: 5.422

4.  Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukaemia.

Authors:  J D Wilson; G J Nossal
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

5.  Rapid preparation of lymphocytes for tissue-typing.

Authors:  R Harris; E O Ukaejiofo
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

6.  Surface immunoglobulins of leukaemic cells.

Authors:  A K Foulis; A J Cochran; J R Anderson
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

7.  Conjugation of fluorescein isothiocyanate to antibodies. I. Experiments on the conditions of conjugation.

Authors:  T H The; T E Feltkamp
Journal:  Immunology       Date:  1970-06       Impact factor: 7.397

8.  Preliminary studies on the synthesis of alpha2-macroglobulin by human lymphocytes in vitro.

Authors:  A M Tunstall; K James
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

9.  Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin.

Authors:  E R Unanue; H M Grey; E Rabellino; P Campbell; J Schmidtke
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

10.  Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation.

Authors:  E Rabellino; S Colon; H M Grey; E R Unanue
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

View more
  3 in total

1.  The effect of anti-alpha2-macroglobulin on K-cell cytolysis and T- and B-cell rosette formation.

Authors:  E A Calder; S J Urbaniak; W J Irvine; K James
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

2.  Identification of pregnancy-associated alpha-macroglobulin on the surface of peripheral blood leucocyte populations.

Authors:  W H Stimson
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

3.  The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia.

Authors:  Naseba Naseraldeen; Regina Michelis; Masad Barhoum; Judith Chezar; Tamar Tadmor; Ariel Aviv; Lev Shvidel; Adi Litmanovich; Mona Shehadeh; Galia Stemer; Ety Shaoul; Andrei Braester
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.